Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up
Authors:
Open Access
- 1 June 2010
- journal article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 16 (6) , 788-791
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Alveolar echinococcosis: From a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 yearsJournal of Hepatology, 2008
- Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosisBritish Journal of Surgery, 2005
- Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: long-term analysis of the Swiss chemotherapy trial (1976–2001)Journal of Hepatology, 2004
- Structured treatment interruption in patients with alveolar echinococcosisHepatology, 2004
- Biological, Epidemiological, and Clinical Aspects of Echinococcosis, a Zoonosis of Increasing ConcernClinical Microbiology Reviews, 2004
- EchinococcosisThe Lancet, 2003
- Pericystic Metabolic Activity in Alveolar Echinococcosis: Assessment and Follow-Up by Positron Emission TomographyClinical Infectious Diseases, 1999
- Effect of mebendazole therapy during pregnancy on birth outcomeThe Lancet, 1999
- Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosisJournal of Hepatology, 1998
- Alveolar echinococcosisHepatology, 1998